Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05598515 · ClinicalTrials.gov registry record · NA
Time-restricted Feeding to Reduce Inflammation in Fanconi Anemia
A NA study of Fanconi Anemia, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 3
- Enrollment target
- 1
- Study location
NCT05598515: Completed NA study of Fanconi Anemia, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT05598515 is a NA study of Fanconi Anemia that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 3 participants, below the 336-participant average among 15 other Fanconi Anemia trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05598515, a NA study of Fanconi Anemia, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
- 1
- Study location
Study Summary
The main reason for this research study is to determine whether time-restricted eating will reduce inflammation in the bodies of persons with Fanconi anemia (FA) and whether time-restricted eating will improve function in people with FA and neurological changes. Participants will be asked to eat for only 8 hours out of 24 hours in a day.
Primary Outcome
Presence of neuroinflammation will be measured with a clinical head MRI
Conditions Studied
Interventions
- BEHAVIORAL Time-Restricted Feeding
Study Locations (1)
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2022-11-11 |
| Est. Completion | 2023-12-07 |
| Phase | NA |
What the finished NCT05598515 record still lists
NCT05598515 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 336-participant average among 15 other Fanconi Anemia trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Fanconi Anemia appearing as the primary indexed condition, and to 1 intervention - of which Time-Restricted Feeding is the first listed.
NCT05598515 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05598515 about?
NCT05598515 is a clinical study titled "Time-restricted Feeding to Reduce Inflammation in Fanconi Anemia". The main reason for this research study is to determine whether time-restricted eating will reduce inflammation in the bodies of persons with Fanconi anemia (FA) and whether time-restricted eating will improve function in people with FA and neurological changes. Participants will be asked to eat for...
What is the current status of trial NCT05598515?
This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2022-11-11. Estimated completion is 2023-12-07.
What conditions does trial NCT05598515 study?
This clinical trial studies the following conditions: Fanconi Anemia.
What interventions are being tested in trial NCT05598515?
The interventions under investigation include: Time-Restricted Feeding (BEHAVIORAL).
Who is sponsoring clinical trial NCT05598515?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05598515 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fanconi Anemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05598515's enrollment target sits among peer trials
3 15th of 15 higher than 1 of 15 other Fanconi Anemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Fanconi Anemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Role of Acetaldehyde in the Development of Oral Cancer
RECRUITING · NA
-
Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer
ACTIVE NOT RECRUITING · NA
-
Hematopoietic Stem Cell Transplantation for Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using Total Body Irradiation, Cyclophosphamide and Fludarabine
COMPLETED · NA
-
Depleted Donor Stem Cell Transplant in Children and Adults With Fanconi Anemia After Being Conditioned With a Regimen Containing Briquilimab
RECRUITING · Phase 1
-
Defining the Natural History of Squamous Cell Carcinoma in Fanconi Anemia
RECRUITING
-
Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI